3-Fluoro-4-iodoquinoline, 97%, 100mg

(4R,4'R)-1,1'-Bis(3-(tert-butyl)phenyl)-4,4'-dicyclohexyl-4,4',5,5'-tetrahydro-1H,1'H-2,2'-biimidazole, 98%, 250mg

2-(DIPHENYLMETHYL)-2,6-DIAZASPIRO[3.4]OCTANE, 95.0%, 25g

7-methoxy-4-oxo-3,4-dihydroquinazolin-6-yl acetate, 100g

5-tert-butyl-1,2,4-oxadiazol-3-amine, 95.0%, 1g

2-chloro-5-methyl-1,3,4-thiadiazole, 95.0%, 250mg

(2-FLUORO-4-NITROPHENYL)(METHYL)SULFANE, 95.0%, 250mg

Ethyl diethoxyacetate, 95.0%, 25g

2,7-Dimethylimidazo[1,2-a]pyridine-3-carboxylic acid, 97.0%, 5g

Methyl 6-(hydroxymethyl)picolinate, 97.00%, 25g

4-Amino-2-bromopyridine, 98.0%, 10g

28-(tert-butoxy)-1-(diazyn-1-ium-1-yl)-28-oxo-4,7,10,13,16,19,22,25-octaoxa-1-azaoctacosan-1-ide, 95%, 500mg

HPTLC Plates RP-18 W / UV254 - octadecyl-modified, 20 x 20 cm, 1.00 mm, 15 Piece(s)